GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 34 filers reported holding GT BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,390 | -0.2% | 88,720 | +29.1% | 0.00% | – |
| Q2 2023 | $21,441 | -43.3% | 68,720 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $37,796 | -37.9% | 68,720 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $60,865 | -49.7% | 68,720 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $120,947 | -41.0% | 68,720 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $205,000 | +606.9% | 68,720 | +587.2% | 0.00% | – |
| Q1 2022 | $29,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crumly & Associates Inc. | 32,163 | $93,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 20,075 | $58,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 28,260 | $81,000 | 0.00% |
| Sigma Planning Corp | 21,400 | $62,000 | 0.00% |
| Compagnie Lombard Odier SCmA | 30,000 | $86,000 | 0.00% |
| Gordian Capital Singapore Pte Ltd | 35,000 | $3,000 | 0.00% |
| Welch Group, LLC | 10,000 | $29,000 | 0.00% |
| Renaissance Technologies | 186,300 | $537,000 | 0.00% |
| BRIGHTON JONES LLC | 11,012 | $32,000 | 0.00% |
| Capital Advisors, Ltd. LLC | 24 | $0 | 0.00% |